Biden to tap Harvard surgeon, clinical trials expert as NCI director
Monica Bertagnolli, an eminent surgical oncologist and physician-scientist, is set to succeed Ned Sharpless as director of the National Cancer Institute.
Although the White House has yet to confirm the appointment, multiple cancer research organizations and patient advocacy groups applauded the choice, including ASCO, where Bertagnolli previously served as president. Currently a professor of surgery at Harvard Medical School, and the chief of the Division of Surgical Oncology at Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Bertagnolli would be the first woman to lead the NCI.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.